Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study

Papenburg, J; Defoy, I; Masse, E; Caouette, G; Lebel, MH

Papenburg, J (corresponding author), McGill Univ, Montreal Childrens Hosp, Hlth Ctr, E05-1905-1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2021; 10 (3): 237

Abstract

Background. Infants born at 33-35 completed weeks' gestational age (wGA) aged <6 months at the start of or born during respiratory syncytial virus ......

Full Text Link